Tired-eye supplement introduced at the American Optometric Association

Article

At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Key Points

Burlington, NJ-At the recent American Optometric Association annual congress, Astavita Professional introduced astaxanthin (AstaREAL, Fuji Health Science) for the relief and prevention of asthenopia.

Asthenopia is characterized by sensitivity to glare, headaches, sore eyes, and blurred vision. Fuji Chemical Industry of Japan's 11 human clinical studies of an all-natural antioxidant-astaxanthin-have shown significant positive results against asthenopia.

Astaxanthin acts as both a lipid-soluble and water-soluble antioxidant to reduce cellular inflammation while protecting cells. Supporting studies have shown that astaxanthin increases capillary blood flow and improves ciliary body function, as well as increases the endurance and recovery of muscles after overuse, exercise, and other forms of stress.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Erin Tomiyama, OD, PhD, FAAO, offers actionable advice for myopia management and perspective for practitioners ready to refine their approach.
Extended lotilaner 0.25% therapy shows meibomian gland benefits
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Carolyn Majcher, OD, FAAO, details a Collaborative Care Symposium 2025 presentation given with Prethy Rao, MD.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Lori Wright, JD, sat down to talk about a presentation at Collaborative Care Symposium about the risk under federal statutes and how to minimize that risk as an optometrist or an ophthalmic practice.
Rachelle Lin, OD, MS, FAAO, on collaborating more effectively on neovascular retinal cases
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
© 2025 MJH Life Sciences

All rights reserved.